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Background: Low Back Pain (LBP) remains a common and costly problem. Psychological obstacles to recovery
have been identified, but psychological and behavioural interventions have produced only moderate improvements.
Reviews of trials have suggested that the interventions lack clear theoretical basis, are often compromised by low dose,
lack of fidelity, and delivery by non-experts. In addition, interventions do not directly target known risk mechanisms.
We identified a theory driven intervention (Contexual Cognitive Behavioural Therapy, CCBT) that directly targets an
evidence-based risk mechanism (avoidance and ensured dose and delivery were optimised. This feasibility study was
designed to test the credibility and acceptability of optimised CCBT against physiotherapy for avoidant LBP patients,
and to test recruitment, delivery of the intervention and response rates prior to moving to a full definitive trial.
Methods: A randomised controlled feasibility trial with patients randomised to receive CCBT or physiotherapy. CCBT was
delivered by trained supervised psychologists on a one to one basis and comprised up to 8 one-hour sessions.
Physiotherapy comprised back to fitness group exercises with at least 60 % of content exercise-based. Patients were
eligible to take part if they had back pain for more than 3 months, and scored above a threshold indicating fear
avoidance, catastrophic beliefs and distress.
Results: 89 patients were recruited. Uptake rates were above those predicted. Scores for credibility and acceptability of
the interventions met the set criteria. Response rates at three and six months fell short of the 75 % target. Problems
associated with poor response rates were identified and successfully resolved, rates increased to 77 % at 3 months, and
68 % at 6 months. Independent ratings of treatment sessions indicated that CCBT was delivered to fidelity. Numbers
were too small for formal analysis. Although average scores for acceptance were higher in the CCBT group than in the
group attending physiotherapy (increase of 7.9 versus 5.1) and change in disability and pain from baseline to 6 months
were greater in the CCBT group than in the physiotherapy group, these findings should be interpreted with caution.
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Conclusions: CCBT is a credible and acceptable intervention for LBP patients who exhibit psychological obstacles to
recovery.
Trial registration: ISRCTN43733490, registered 15/12/2010.
Keywords: Feasibility trial, Randomised controlled trial, Chronic back pain, Fear avoidance, Contexual cognitive
behavioural therapy, Acceptance and commitment, Sub-groups, Physiotherapy, Acceptability & credibilityBackground
Low back pain continues to be a major cause of disability
worldwide [1]. Psychological obstacles for recovery have
been identified [2], and psychological interventions, pri-
marily based on cognitive-behavioural approaches (CBT),
have been tested in many trials. There are several system-
atic reviews of such trials in musculoskeletal pain popula-
tions, and in LBP specifically [3–6]. The findings across
reviews suggest that CBT is marginally superior to treat-
ment as usual, but the effect sizes for key outcomes are
small (around 0.2) and the clinical significance of these
effects remain unclear [7].
Several explanations have been suggested for the dis-
appointing findings. These include diluted interventions,
in which psychology is offered by non-psychologists who
are untrained or trained only for the purposes of the
trial; psychology offered at minimal doses; the inclusion
of heterogeneous groups and the failure to select and
target sub-groups who would benefit from psychological
interventions; and the failure to apply theoretically-
driven interventions that directly address mechanisms or
processes theoretically identified and demonstrated as
necessary in producing positive outcomes [8, 9].
Fear avoidance, catastrophic thinking and emotional
distress have all been identified as factors contributing
to poor outcomes [10, 11] indicating sub-groups with
high risk. The principle of stratified care, in which
patients are screened to identify sub-groups, and
referred to matching interventions, has been shown to
improve outcomes [12]. However the interventions,
based on CBT approaches, have been less effective for
high-risk groups with complex psychological factors
[12]. Other psychological interventions, developed
specifically to address these risk factors include
exposure-based interventions. While case studies of
exposure based methods have appeared promising,
RCTs including these methods have appeared more
limited in their success [13, 14]. The model underlying
these treatments has been criticised as missing key
therapeutic elements, such as specifically identified
therapeutic processes, and an approach to positive goals
and motivation [15]. Exposing patients to feared move-
ments does not appear to generalise to everyday activities
[16]. Optimal treatment for these patients remained
unknown.A model that may be more adequate for addressing
fear avoidance, catastrophic thinking, and other emo-
tional factors, and that includes specific therapeutic pro-
cesses and an approach to goals and motivation, is the
psychological flexibility model [17, 18]. Treatment ap-
proaches based on this model include Acceptance and
Commitment Therapy [19] and can be more generically
referred to as Contextual Cognitive-Behavioural Therapy
(CCBT) [9, 20, 21].
The current study was designed to overcome the
limitations associated with previous trials, by select-
ing patients for evidence-based risk profile and
offering a theoretically-based intervention, previously
untested in LBP in a full RCT, which explicitly aims
to target this risk profile. The intervention was
designed to full integrity, delivered by experienced
psychologists extensively trained and supervised, on
a one to one basis and to sufficient dose [8]. Cred-
ible control conditions have also been highlighted
as an area for improvement in trials [7]. The
current study included a control arm of best prac-
tice as recommended by guidelines, by offering
physiotherapy [22].
The primary objectives of the study were to test the
credibility and acceptability of offering CCBT to pa-
tients with high fear avoidance who had been referred
to physiotherapy, assess recruitment processes and
study uptake, assess the burden of measurement tool
completion at baseline and follow-up time points, and
test whether psychologists inexperienced in CCBT
could be trained to deliver CCBT to integrity. The
secondary objectives were to measure changes in Quality
of Life outcomes relating to mood, pain, disability and
functioning.Methods
Design
We conducted a feasibility RCT comparing CCBT with
physiotherapy in four NHS Musculoskeletal / Physio-
therapy Services in England between September 2010
and December 2013 (see [9] for details). The study
was approved by The National Health Service ethics
committee, and at university level at Royal Holloway,
University of London.
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Participants experiencing chronic low back pain, suit-
able for physiotherapy-led treatment, classified as
“avoidant” (defined via meeting set thresholds by
endorsing at least one of the items measuring cata-
strophic beliefs, depression and fear avoidance on the
Targeted Treatment for Back Pain (STarT Back)
Screening Tool and scoring above 38 on the 17 item
Tampa Scale for Kinesiophobia (TSK) [23]) were
eligible for recruitment. The recruitment process was
as follows: all referrals made to the musculoskeletal /
physiotherapy services involved in the study were
triaged by physiotherapy researchers. Those patients
suitable were sent a screening questionnaire, and
replies included consent to be contacted by the
researcher. The Researcher contacted patients to fur-
ther clarify eligibility and if eligible, invited the patient
to attend a Physiotherapy Assessment and a face-to-
face meeting with the Researcher. The Physiotherapy
Assessment excluded sciatica or any other progressive
disorders that may require a different clinical pathway.
Eligible patients then meet face to face with the Re-
searcher, and provided written informed consent.
Baseline data were collected prior to randomization.
Randomisation and allocation concealment
Consenting participants were randomised on a 1:1
basis to receive either CCBT or physiotherapy. This
was carried out by remote computerised randomisa-
tion, which the researcher communicated to patients
during the interview, after obtaining full informed
consent.
Trial interventions
1. CCBT was delivered by trial-specific psychologists
trained in the intervention and supervised by the
co-applicant expert (LM). Participants allocated
CCBT were offered up to 8 individual sessions, of
50 min each. Session content was not structured,
and at the discretion of therapists, included any
features of CCBT they thought were appropriate
at the point with that patient. The first session is
dedicated to building a good relationship with
patients and setting their expectations about the
content and rationale of subsequent treatment.
Subsequent sessions included a mixture of
techniques based on enhancing acceptance through
experiential, exposure-based, and mindfulness-based
methods, using a present-moment focus, directed
awareness, and values-based action. The number of
sessions required by each individual patient was agreed
between the patient and therapist.Physiotherapy was delivered as usual within services,
with the stipulation that it included at least 60 % exer-
cise and comprised group sessions (in total not exceed-
ing 8 sessions), with an allowance of up to 3 individual
sessions at the start of treatment if required. This was a
pragmatic trial, and physiotherapy reflected the variabil-
ity within the service. The general goal of physiotherapy
was to encourage re-activation. We monitored the con-
tent through self-report by the physiotherapists in short
forms and observation sessions by a physiotherapist ex-
pert (AM) to ensure fidelity. However the exact content
of the physiotherapy sessions could vary between thera-
pists and patients, as is typical in the real world.
Both interventions were monitored for fidelity of treat-
ment content and delivery.
Data collection
Data were collected from participants at baseline via re-
searcher interview, and via 3 and 6 months postal and
telephone questionnaires post-randomisation. The fol-
lowing questionnaires were completed at all time-points
unless otherwise stated: TSK [23], Brief Pain Inventory
(BPI [24–26]), Chronic Pain Acceptance Questionnaire
(CPAQ [27]), Acceptance and Action Questionnaire
(AAQ-II [28]), Roland Morris Disability Questionnaire
(RMDQ [29]), Short Form 12 (SF12 [30]), Hospital Anx-
iety and Depression Scale (HADS [31]), EuroQol-5D
(EQ-5D™[32]), Modified Patient Global Impression of
Change (PGIC [33, 34]), expectations of and satisfaction
with treatment was measured using questions adapted
from those used by Borkovec and Nau [35] (at baseline
and 3 months). The information that all patients re-
ceived at the stage of providing credibility ratings about
the CCBT intervention was as follows:
a) On the information sheet: If you are having the
behavioural treatment, CCBT. “Behavioural” means
the treatment is aimed at training you in skills and
in changing behaviour patterns to improve your
health and daily activities. Both treatments are
known to be safe and are already used in some
hospitals. you will need to come for a meeting with
a psychologist (who specialises in helping people in
pain) once a week for up to 8 weeks.
b) Assessing physiotherapist: ‘There are several
interventions for your type of pain, and currently it
is not known which of them is most effective. Two
of them are physiotherapy and a talking therapy
called Contextual Cognitive Behavioural Therapy-
CCBT.’
c) Pre randomisation, by the researcher consenting
participants: ‘CCBT involves a psychologist talking
to patients about their back pain including their
thoughts and feelings about pain. This is to help
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thoughts and behaviour and to lead a fuller life.’
Qualitative study
To qualitatively assess acceptability and credibility of
treatment, recruitment and follow-up processes, par-
ticipants were interviewed at 3 months and therapists
were interviewed at the end of the study.
Sample size
Being a feasibility study, formal power calculations were
not appropriate as the study was not designed to test for
a difference between treatments. We followed recom-
mendations to have a minimum of 30 participants per
group [36], and set a target of 92 recruited participants
was set, allowing for 35 % loss of data (25 % due to loss
to follow-up and 10 % due to non-compliance).
The study was approved by the West London Research
Ethics Committee (Reference: 11/H0706/9) and funded
by Arthritis Research UK (Grant reference: 19401).
Analyses
Combinations of qualitative and quantitative measures
were used to address the primary research questions of
assessing the acceptability and credibility of CCBT to pa-
tients and therapists; the viability of recruitment processes
and acceptability of outcome measures for a future defini-
tive trial. Analyses conducted were mainly descriptive and
focussed on confidence interval estimation, rather than
hypothesis testing, to provide estimates of the key trial
parameters to determine whether to proceed to a larger
definitive RCT. All analyses were conducted on an
intention-to-treat basis with participants being analysed
according to their randomisation allocation. Data were
analysed at the end of the study when all data collection,
entry and validation was completed. A-priori criteria to
proceed to a larger definitive trial were established upfront
in consultation with the Trial Steering Committee and are
detailed below.
Credibility and acceptability scores were summarised
by group. To assess credibility, mean scores and 95 %
confidence intervals were calculated overall and by rando-
mised group for the first two questions of the Borkovec
and Nau expectation and satisfaction questionnaire [35]
(details in Table 2). To assess acceptability, mean scores
and 95 % confidence intervals of each of the five Borkovec
and Nau questions were calculated by randomised group.
ANCOVA (adjusting for baseline value as a covariate) was
also used to calculate the change from baseline to three
month scores for the first two Borkovec and Nau, together
with 95 % confidence intervals. In addition, treatment
dropouts, the number of participants missing treatment
sessions and withdrawing (from treatment, follow-up or
both) in each arm was summarised.To further assess acceptability, qualitative analyses
were conducted independently by two researchers on
the participant three-month interviews (TP & JH). Di-
rected content was used to explore consensus, and present
the analysis backed by verbatim quotes to illustrate main
points. Errors, omissions and commission were discussed
and resolved between the researchers. Information from
interviews with practitioners at the end of the trial was
discussed and synthesised with data from patients, where
appropriate.
Recruitment and follow-up strategies were measured
by summarising eligibility, consent and randomisation
rates both overall and by centre. The acceptability of
measurement tool completion was assessed by summar-
ising follow-up response rates overall and by arm at all
time-points, by assessing the level of missing data (for
individual items and for entire outcome measures) and
via responses provided during the three-month partici-
pant interview.Proof of principle and secondary analyses
Proof of principle was measured by change from baseline
to three and six months on CPAQ Total score, sum-
marised by point estimated and 95 % confidence intervals.
Secondary outcome measures relating to QOL (BPI, TSK,
RDQ, SF12, Hospital Anxiety and Depression Scale) and
recovery post treatment at six months follow up were
summarised by point estimates and 95 % confidence inter-
vals and presented by randomised group, at each time point.A-priori criteria for credibility, acceptability and feasibility
The following a-priori criteria were established to assess
whether to proceed to a larger definitive trial.
Criteria for acceptability and credibility were set at a
score of at least five points out of the maximum of 10 on
each of the Borkovec and Nau items [9]. The mid-point
response was considered sufficient in consideration that
patients would have been referred to physiotherapy, and
were expected to therefore have higher expectations for
physiotherapy.
An acceptable level of treatment completion was set at
90 % of randomised patients completing allocated treat-
ment. This definition does not take into account the
number of sessions attended, because individual patients
may have required different doses of treatment. Comple-
tion was therefore defined as cases where both therapist
and patient agreed that treatment was completed.
To proceed to a larger trial, at least 3 % of all those re-
ferred should be recruited and at least 20 % of patients
completing a screening questionnaire should be recruited.
In addition loss of data for analysis should not exceed
35 % post randomisation (10 % due to non-compliance
and 25 % loss to follow up).
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in CPAQ and the AAQ-II scores should be greater in
the group receiving CCBT than the control group, but
this could not be tested explicitly due to the lack of
power in our small sample [37]. Instead we planned to
report means and 95 % CI.
Results and discussion
Recruitment
The recruitment process is described in Fig. 1. Between
August 2012 and April 2013 1448 referrals were screened
from four centres across England of which 1,300 (89.8 %)
were sent screening questionnaires. 131 (9.0 %) of those
referred and sent questionnaires appeared eligible upon
receipt of completed questionnaires. After physiotherapy
assessment for eligibility (n = 104), 89 participants were
randomised into the trial (45 in the CCBT group and 44
in the Physiotherapy group), comprising 86 % of those
eligible to attend for physiotherapy assessment (Fig. 1).
Recruitment between centres differed: two centres re-
lied on referrals from pain services and pain consul-
tants, and did not recruit sufficient numbers into the
trial (n < 5), so recruitment was suspended in these two
centres. Exploration of the reasons for not recruiting
suggested lack of equipoise and insufficient number of
lower back pain referrals without further complications.
The remaining two centres were large primary care-
based Musculoskeletal / Physiotherapy Services with re-
ferrals coming from GP practices.
Participants’ characteristics
The intervention groups were well balanced at baseline
for most characteristics (Table 1). There were more female
participants than male participants in both groups. BPI
pain interference score was similar between the groups.
The CCBT group had a shorter duration of pain than the
Physiotherapy group (median of 27 vs. 36 months). 44 %
of participants indicated that this was their first episode of
pain, but all had experienced pain for more than three
months. When compared to the CCBT group, around
20 % more participants in the Physiotherapy group were
working full / part-time at baseline. The majority of those
recruited had received formal education, and just over half
of these left school aged 16 or less.
Training and supervision frequency
The number of training sessions varied between psycholo-
gists, but all received four full days of face-to-face training
and were given reading to complete in their own time.
The pattern of supervision was similar across therapists,
with a weekly hour telephone session required in the first
month or two, as part of training, followed by one every
two weeks for another two months, and finally a single
monthly session.Acceptability and credibility
Patients randomised to CCBT indicated that the inter-
vention was credible (as average scores for the first two
questions on the Borkovec and Nau Expectation and
Satisfaction Questionnaire [35] exceeded the set cut-
point of 5, Table 2). Nonetheless, and as expected, scores
were higher in the group randomised to the original re-
ferred treatment, physiotherapy (mean of 6.7 vs. 8.9, and
6.6 vs. 8.1 respectively). Mean scores in the CCBT arm
at three months for four of the Borkovec and Nau ques-
tions were above 5, but one item (How successful do
you think this treatment will be / was in reducing the
impact of pain?) was rated 4. For physiotherapy, credibil-
ity scores ranged between 6.2 and 7.4. When adjusted
per protocol for baseline scores, the first two questions
(which ask how logical the treatment seemed, and about
treatment’s success in reducing the impact of pain) were
5.4 (95 % CI 4.43, 6.46) and 4.2 (95 % CI 3.10, 5.39) for
CCBT and 6.5 (95 % CI 5.47, 7.51) and 6.0 (95 % CI
4.91, 7.05) for physiotherapy.
Neither group required on average as many sessions as
anticipated. Attendance at treatment was similar between
the groups, participants in the CCBT group attended on
average 2.6 sessions (2.6 SD), whilst those in the Physio-
therapy group attended on average 2.3 sessions (2.3 SD).
Interviews with the CCBT group indicated that pa-
tients attending CCBT had a strong preference for one-
to-one therapy. Just under half of those interviewed
stated a preference for receiving some physiotherapy
alongside CCBT. Patients also reported that strategies
learnt during CCBT could be recalled, and used outside
of treatment, and that outcome measures were clear
and of acceptable length.
Interviews with therapists suggested that the while the
training plans worked, there was a need to apply the
acquired treatment skills with patients and complete
practice in delivery with at least three patients before
therapists felt competent to offer CCBT to a standard
they regarded as competent. Therapists also reported
that at times they felt introducing the concept of
CCBT to patients was more difficult because patients
knew they had been referred to physiotherapy, and
therefore believed they required physiotherapy. Thera-
pists would have preferred patients to receive some
physiotherapy alongside CCBT. Finally, therapists re-
ported that despite the screening criteria that had
been designed to select patients with high avoidance
levels and psychosocial obstacles to recovery, they felt
that some patients were reasonably adjusted and cop-
ing, and needed very little CCBT.
Feasibility
Overall follow-up rates were 73.0 % at three months (33
CCBT participants; 32 Physiotherapy participants) and
Date Started Screening: 23.08.2011  Date First Patient Recruited: 12.10.2011    Date Last Patient Recruited: 05.04.2013
%
Estimated 
in the 
Grant 
Application
50%
15%
7.3%
3.7%
All % calculated from the number of referrals screened. 
Number of Referrals Screened
1,448
Number of Questionnaires 
Sent /Given 
1,300 (89.8%)
Number of Questionnaires 
Returned 
428 (29.6%)
Number Invited for Assessment
131 (9.0%)
Number Undergone Assessment
104 (7.2%)
Number Randomised 
89 (6.1%)
Questionnaires Not Sent / Given = 148
(Reasons presented in Table 1.1)
Not Eligible = 297
(Reasons presented in Tables 1.2 & 1.3)
Not Undergone Assessment = 27
(Reasons presented in Table 1.4)
Not Randomised = 15
(unsuitable for trial)
Fig. 1 Flow chart of recruitment (Additional file 1)
Pincus et al. BMC Musculoskeletal Disorders  (2015) 16:147 Page 6 of 1160.7 % at six months (26 CCBT participants; 28 Physio-
therapy participants). From June 2012, around half way
through the study, procedures for collecting outcome datawere enhanced (additional reminders, option to complete
with the researcher, and introduction of incentives), to ad-
dress low response rates. Response rates were higher at
Table 1 Baseline characteristics by arm
CCBT (n = 45) N (%) Physiotherapy (n = 44) N (%) Total (n = 89) N (%)
Gender: Male 18 (40.0 %) 17 (38.6 %) 35 (39.3 %)
Age (years): Mean (standard deviation) 43.7 (16.33) 45.4 (15.82) 44.6 (16.01)
Main employment status
Working full time 18 (40.0 %) 24 (54.5 %) 42 (47.2 %)
Working part time 5 (11.1 %) 7 (15.9 %) 12 (13.5 %)
At home and not looking for work 5 (11.1 %) 2 (4.5 %) 7 (7.9 %)
Unemployed and looking for work 7 (15.6 %) 1 (2.3 %) 8 (9.0 %)
Retired 8 (17.8 %) 7 (15.9 %) 15 (16.9 %)
Unable to work 1 (2.2 %) 2 (4.5 %) 3 (3.4 %)
Other 1 (2.2 %) 1 (2.3 %) 2 (2.2 %)
Age participant left full time education (n = 43) (n = 41) (n = 84)
16 or less 25 (58.1 %) 21 (51.2 %) 46 (54.8 %)
17-20 12 (27.9 %) 13 (31.7 %) 25 (29.8 %)
21 or over 6 (14.0 %) 6 (14.6 %) 12 (14.3 %)
Unknown 0 (0.0 %) 1 (2.4 %) 1 (1.2 %)
BPI pain interference score < =5 25 (55.6 %) 25 (56.8 %) 50 (56.2 %)
Duration of current episode of lower back pain (months) (n = 45) (n = 43) (n = 88)
Mean (standard deviation) 42.4 (37.97) 44.6 (36.09) 43.5 (36.87)
Median (range) 27.0 (3.0, 99.0) 36.0 (3.0, 99.0) 36.0 (3.0, 99.0)
First episode of pain: Yes 21 (46.7 %) 18 (40.9 %) 39 (43.8 %)
Other treatment received in the past (n = 24) (n = 26) (n = 50)
Physiotherapy 12 (50.0 %) 19 (73.1 %) 31 (62.0 %)
Medication 17 (70.8 %) 18 (69.2 %) 35 (70.0 %)
Manipulation 8 (33.3 %) 7 (26.9 %) 15 (30.0 %)
Acupuncture 5 (20.8 %) 4 (15.4 %) 9 (18.0 %)
Chiropractor 1 (4.2 %) 1 (3.8 %) 2 (4.0 %)
Osteopath 2 (8.3 %) 0 (0.0 %) 2 (4.0 %)
Other 3 (12.5 %) 6 (23.1 %) 9 (18.0 %)
None 3 (12.5 %) 2 (7.7 %) 5 (10.0 %)
Table 2 Average raw Borkovec & Nau scores by arm and by time point
Baseline 3 months
Question CCBT
Mean
(SD)
N Physiotherapy
Mean (SD)
N Total
Mean
(SD)
N CCBT
Mean
(SD)
N Physiotherapy
Mean (SD)
N Total
Mean
(SD)
N
Q1 – How logical does / did the treatment
offered seem to you?
6.7
(2.89)
44 8.9 (1.62) 44 7.8
(2.58)
88 5.0
(3.28)
31 6.9 (2.70) 31 6.0
(3.13)
62
Q2 – How successful do you think this treatment
will be / was in reducing the impact of pain?
6.6
(2.69)
44 8.1 (1.73) 44 7.3
(2.38)
88 4.0
(3.26)
27 6.2 (2.73) 31 5.2
(3.17)
58
Q3 – How confident would you be in
recommending this treatment to a friend?
N/A N/A N/A 5.4
(3.82)
27 7.4 (2.86) 31 6.5
(3.47)
58
Q4 – How interesting and engaging was the
treatment overall?
N/A N/A N/A 6.5
(3.04)
27 6.4 (3.07) 31 6.4
(3.03)
58
Q5 – How satisfied were you with the overall
quality of the treatment?
N/A N/A N/A 6.6
(3.10)
27 7.0 (3.04) 31 6.8
(3.05)
58
Only the first two questions of the Borkovec & Nau were asked at baseline. The baseline questionnaire was completed post randomisation but prior to
starting treatment
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plemented (76.9 % vs. 62.5 % at three months and 67.5 %
versus 16.7 % at six months). Analysis of the three-month
interviews suggested that patients felt the measures they
were asked to complete were clear, and the length of the
questionnaire was acceptable.
Fidelity
Independent review of a sample (n = 25) of CCBT session
audiotapes, using a structured coding format developed
by LM indicated that an acceptable level of CCBT had
been delivered. These were sampled to include all ther-
apists, and instances of first, middle and last sessions.
The reviewer reported that the majority of recorded
sessions showed evidence for the key CCBT processes
being addressed including Cognitive Defusion, Accept-
ance, Present Moment Awareness and Values-based
Action. Therapists particularly frequently addressed
‘Exploration of feelings/ sensations’ in depth and less
often demonstrated observable behaviours addressing
‘Self as Context, which might indicate a training need’.
The reviewer concluded that CCBT was delivered to fi-
delity and that there was very little evidence of the use
of traditional CBT methods.
Physiotherapy fidelity was established through a) exit
interviews with a sample of patients, b) observation of
one session in each centre by an expert physiotherapist
from the research team, and c) through exploration ofTable 3 Baseline adjusted means and 95 % confidence intervals by
Baseline – 3 Months
Questionnaire CCBT Mean
(95 % CI)
N Physiothera
(95 % CI)
Brief Pain Inventory – Pain Severity
Index
14.9
(12.38, 17.46)
23 15.0 (12.64,
Brief Pain Inventory – Function
Interference Index
25.6
(19.20, 31.92)
21 23.8 (18.11,
Chronic Pain Acceptance – Activity
Engagement
42.0
(38.16. 45.90)
29 44.4 (40.72,
Chronic Pain Acceptance # – Pain
Willingness
- -
Chronic Pain Acceptance – Total Score 65.6
(61.43, 69.82)
29 66.8 (62.80,
Acceptance and Action 21.7
(19.27, 24.22)
32 18.3 (15.81,
Roland Morris Disability 9.4 (7.60, 11.17) 23 8.6 (6.94, 10
Hospital Anxiety and Depression -
Anxiety
7.7 (6.42, 9.07) 23 7.65 (6.45, 8
Hospital Anxiety and Depression -
Depression
5.3 (4.26, 6.25) 22 5.4 (4.44, 6.
The TSK is not included in the table above as it could not be appropriately analysed
at screening
# The CPAQ Pain Willingness subscale could not be appropriately analysed between
treatment and score at baseline
Negative differences indicate higher scores in the Physiotherapy arm whilst positivthe physiotherapy session rating forms, which detailed
the components covered in each session.
Proof of principle and secondary outcomes
The majority of outcomes of both groups improved, on
average, over six months post randomisation (Table 3).
Changes from baseline to six months in acceptance
scores suggested that CCBT increased acceptance more
than did physiotherapy with an increase, on average of
7.9 on total acceptance (CPAQ) in CCBT compared to
5.1 in physiotherapy. At baseline, mean scores for CCBT
and physiotherapy for the RDQ were 11.6 (4.78) and
11.7 (5.27), at three months, 9.0 (6.31) and 8.9 (6.74)
and at 6 months, 7.1 (4.10) for CCBT and 8.8 (5.64) for
physiotherapy. No adverse events were reported.
Discussion
This feasibility study demonstrated that CCBT was
credible and acceptable to patients with LBP, and that
psychologists could be trained to deliver CCBT to integ-
rity in a reasonably short time frame.
However, findings from both patients and therapists
suggest that patients randomised to CCBT should also
receive a minimal amount of physiotherapy in conjunction
with CCBT. In this study, credibility ratings were a little
lower for CCBT than for physiotherapy as usual. A full
trial that provided a combination of physiotherapy and
CCBTagainst physiotherapy alone would probably achievemeasure, arm and time point comparison
Baseline - 6 months
py Mean N CCBT Mean
(95 % CI)
N Physiotherapy Mean
(95 % CI) N
N
17.42) 26 13.8
(10.39, 17.17)
23 13.7 (10.31, 17.09) 23
29.52) 26 21.6
(15.88, 27.24)
23 25.4 (19.56, 31.17) 22
48.07) 32 43.5
(39.93, 47.07)
25 45.5 (42.02, 49.02) 26
26.0
(22.79, 29.23)
25 23.3 (20.12, 26.43) 26
70.78) 32 69.3
(64.23, 74.44)
25 69.0 (63.96, 73.96) 26
20.76) 32 20.6
(18.03, 23.13)
26 19.1 (16.56, 21.67) 26
.30) 26 7.3
(5.86, 8.75)
23 8.6 (7.16, 10.12) 22
.85) 27 7.8 (6.36, 8.96) 23 7.2 (5.87, 8.47) 23
28) 26 4.5 (3.34, 5.65) 23 4.8 (3.61, 5.92) 23
due to a significant interaction effect between treatment and score
3 months and baseline due to a significant interaction effect between
e differences indicate lower scores in the Physiotherapy arm
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fact that small numbers did not enable inferential testing,
changes in both acceptance and disability were greater in
the group receiving CCBT than the control physiotherapy,
suggesting that the intervention is promising.Strengths and weaknesses
This study was designed to address limitations identified
with current trials of psychological intervention for people
with back pain. Our intervention was theoretically matched
to known risk factors, and we attempted to combat the
common practice of diluting the intervention by delivery
from trained and supervised clinical psychologists, in one
to one sessions, and at a credible dose. Despite this the
study has limitations. This was a feasibility trial, and as
such, was not powered to inform on the superiority of
either of the interventions. The findings suggest that
there is room to improve delivery (through inclusion of
physiotherapy in conjunction with CCBT); method-
ology, especially in reference to collecting longer-term
outcome data. The study findings are based on treat-
ment delivery of CCBT by two therapists (although we
trained four), in two centres, and therefore may not
represent wider populations of patients and therapists.
Both qualitative and quantitative data suggested
that some patients were well adjusted on entry to the
study, despite our screening thresholds. Improve-
ments on both screening and eligibility criteria are
therefore indicated for a definitive trial, to ensure
that the trial recruits the patients most likely to
benefit from CCBT. For example, despite using fear-
avoidance (38+ on the TSK), and a single item on the
psychological sub-set of the STartBack Tool as entry
requirements, therapists often reported that they
considered patients to be reasonably adjusted. Con-
sidering the cost implications of providing one to one
CCBT sessions, a more stringent cut point for high
risk may be more useful. For the sample in this study,
8 sessions were not needed, and most patients
successfully completed treatment with only 2–3 ses-
sions. This may not be sufficient for a population
with more severe adjustment problems, and consid-
ering the criticism of other trials compromising
psychological interventions by reduced dose, the dose
offered in a definitive trial will need careful
consideration.
Our findings suggest that the best placed centres to
recruit to a definitive trial are centres in which there
is a steady referral from general practices to physio-
therapy, rather than recruitment through pain ser-
vices in secondary care. In reference to lower than
expected response rates, the findings suggest that
this is a particular risk for a definitive trial, possiblybecause of the complexity of the target population.
We devised strategies to increase the response rate to
an acceptable level at three months and close to ac-
ceptable levels at six months, through maximising
the use of reminders, phone calls and incentives.
Although we succeeded in monitoring fidelity
through audiotaping in this pilot study, this method
is unlikely to be practical in a large trial. Audiotaping
sessions during training is probably a useful practice,
but routine monitoring of delivery in a definitive trial
might need to be done through form completion by
therapists and analysis of exit interviews, accompan-
ied by a small sample of audiotaped sessions.
Finally, around half of the participants in the
current study reported leaving school before age 16.
This might have impacted on their ability to grasp
and use some of the more cognitive content of the
CCBT intervention. We note, however, that the ex-
periential nature of the CCBT approach would be
more suitable than other interventions that rely more
heavily on intellectual and verbal input.Fit with other studies
CCBT belongs within interventions that are largely
based on psychological flexibility model [18], of
which the most common label is Acceptance and
Commitment therapy (ACT). ACT, which formed the
basis for our intervention, has been tested with sev-
eral other groups of patients, and continues to show
promise. ACT is now recommended as a priority for
research in several guidelines [36, 38]. However, a re-
view of the evidence suggests that the need for a de-
finitive trial in low back pain populations remains a
priority: We identified 14 RCTs in other pain populations
including pilot studies: 3 large (n ≥100), 5 medium (100 >
n ≥50) and 6 small (n <50). Overall, reviews of trials that
include ACT-related interventions [39] conclude that
acceptance-based interventions appear to be beneficial in
chronic pain conditions, although currently the evidence
is limited. Most recommend conducting well-designed
large-scale trials to ascertain the effectiveness. The
information from the RCTs suggests acceptance-based
interventions, such as ACT, have some benefit for chronic
pain, however, there is a lack of high-quality quality
evidence and further large-scale RCTs are warranted.Implications
These findings, together with other evidence, help direct
future trials. We should now build on our knowledge
that we need to a) empower patients to make sustainable
lifestyle changes within a biopsychosocial framework, b)
tailor our treatments to the needs of the individual, and
c) combine the expertise of physical therapists and
Pincus et al. BMC Musculoskeletal Disorders  (2015) 16:147 Page 10 of 11psychologists- not just a single professional discipline -
working together.
This means targeting outcomes that are applicable to
daily living and easily generalise across life-spheres,
screening patients and matching interventions to their
specific needs, and creating cross-disciplinary syner-
gies to deliver theoretically-fused interventions with
agreed goals. Specifically, our findings suggest that a
definitive trial of optimised behavioural treatment for
patients with LBP who are high risk could offer CCBT,
but should include a synthesis of physiotherapy and
CCBT delivered by highly skilled clinicians.
Conclusion
The findings from this study suggest that CCBT is cred-
ible, acceptable and promising for people with LBP who
are also experiencing high levels of avoidance and dis-
tress. There is a need for a definitive trial using CCBT
or related interventions, optimised by delivery, but com-
bined with physiotherapy, to test improvements long
term against credible controls.
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